Background: B-lymphoproliferative post-transplant disorder (BLPD) is a severe complication
of organ and bone marrow transplantation. The reduction of immuno-suppressive therapy or …

Purpose Trastuzumab plus chemotherapy has become the standard of care for human
epidermal growth factor receptor-2 (HER-2)–positive breast cancer. Trastuzumab-based …

… Different etiologies are involved in HCC development including cirrhosis, hepatitis B and
C virus infection, excessive alcohol consumption and obesity [3]. For patients that are …

Purpose: Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) are
used to determine human epidermal growth factor receptor-2 (HER-2) status and patient …

… (B) Application of the electric pulses using a linear needle electrode inserted into the cutaneous
… (B) Baseline. (C) One week after first treatment. (D) One week after second treatment. …

Background Cytotoxic chemotherapy is generally ineffective in patients with hepatocellular
carcinoma. We assessed the intravenous perfusion of doxorubicin-loaded nanoparticles in …

Neuroblastoma shows remarkable heterogeneity, ranging from spontaneous regression to
progression toward highly malignant tumors. In search of genetic abnormalities that could …

Purpose/Objectives: To evaluate the intermediate term efficacy and toxicity of the use of
venlafaxine for the control of hot flashes. Design: An open-label continuation phase study …

… In summary, herein we have shown that DT might improve OS in patients with BCLC-B/C
HCC. Global tolerance was manageable with the exception of the occurrence of some severe …

Background Patients with advanced non-small-cell lung cancer (NSCLC) treated with immune
checkpoint blockers (ICBs) ultimately progress either rapidly (primary resistance) or after …